T3	Effect 20 60	fulminant neuroleptic malignant syndrome
T4	Subject 64 77	a man aged 70
T6	Treatment 117 154	six-hourly intravenous metoclopramide
T7	Gender 66 69	man
T8	Age 70 77	aged 70
T9	Time_elapsed 89 104	within 12 hours
T10	Route 128 139	intravenous
T11	Drug 140 154	metoclopramide
T12	Freq 117 127	six-hourly
T5	Adverse_event 78 88	developing
E1	Adverse_event:T5